Medication or Class of Medications |
Section A
Do YOU believe this is a high-alert medication? |
Section B
Does YOUR PRACTICE SITE consider this a high-alert medication with special precautions in place? |
|
| A. Current List |
Yes |
No |
Yes |
No |
|
| 1. Adrenergic agonists, IV (e.g., epinephrine) |
84% |
16%
|
63%
|
37%
| |
| 2. Adrenergic antagonists, IV (e.g., propranolol) |
56% |
44%
|
41%
|
59%
| |
| 3. Anesthetic agents, general, inhaled and IV (e.g., propofol) |
86% |
14%
|
68%
|
32%
| |
| 4. Cardioplegic solutions |
77% |
23%
|
54%
|
46%
| |
| 5. Chemotherapeutic agents, parenteral |
97% |
3%
|
90%
|
10%
| |
| 6. Chemotherapeutic agents, oral |
78% |
22%
|
66%
|
34%
| |
| 7. Dextrose, hypertonic, 20% or greater |
70% |
30%
|
51%
|
49%
| |
| 8. Dialysis solutions, peritoneal and hemodialysis |
58% |
42%
|
39%
|
61%
| |
| 9. Epidural or intrathecal medications |
93% |
7%
|
79%
|
21%
| |
| 10. Glycoprotein IIb, IIIa inhibitors (e,g, eptifibatide) |
64% |
36%
|
51%
|
49%
| |
| 11. Hypoglycemics, oral |
31% |
69%
|
21%
|
79%
| |
| 12. Inotropic medications, IV (e.g., digoxin, milrinone) |
67% |
33%
|
50%
|
50%
| |
| 13. Liposomal forms of drugs (e.g., liposomal amphotericin B) |
57% |
43%
|
44%
|
56%
| |
| 14. Moderate sedation agents, IV (e.g., midazolam) |
69% |
31%
|
59%
|
41%
| |
| 15. Moderate sedation agents, oral, for children (e.g., midazolam, chloral hydrate) |
78% |
22%
|
62%
|
38%
| |
| 16. Narcotics and opiates, IV, transdermal, transmucosal, oral (including liquid concentrates, immediate/sustained release) |
79% |
21%
|
68%
|
32%
| |
| 17. Neuromuscular blocking agents (e.g., succinylcholine) |
94% |
6%
|
78%
|
22%
| |
| 18. Radiocontrast agents, IV |
55% |
45%
|
43%
|
57%
| |
| 19. Thrombolytics/fibrinolytics (e.g., tenecteplase) |
83% |
17%
|
70%
|
30%
| |
| 20. Total parenteral nutrition solutions |
55% |
45%
|
50%
|
50%
| |
| 21. IV amiodarone |
70% |
30%
|
55%
|
45%
| |
| 22. Colchicine injection |
48% |
52%
|
29%
|
71%
| |
| 23. Heparin, low molecular weight, injection |
61% |
39%
|
54%
|
46%
| |
| 24. Heparin, unfractionated, IV |
85% |
15%
|
80%
|
20%
| |
| 25. Insulin, subcutaneous |
77% |
23%
|
73%
|
27%
| |
| 26. Insulin, IV |
93% |
7%
|
88%
|
12%
| |
| 27. Lidocaine, IV |
70% |
30%
|
57%
|
43%
| |
| 28. Magnesium sulfate injection |
70% |
30%
|
59%
|
41%
| |
| 29. Methotrexate, oral, non-oncologic use |
56% |
44%
|
45%
|
55%
| |
| 30. Nitroprusside, sodium, injection |
75% |
25%
|
62%
|
38%
| |
| 31. Potassium chloride for injection |
93% |
7%
|
86%
|
14%
| |
| 32. Potassium phosphates injection |
87% |
13%
|
77%
|
23%
| |
| 33. Sodium chloride injection, hypertonic, more than 0.9% concentration |
83% |
17%
|
71%
|
29%
| |
| 34. Warfarin |
67% |
33%
|
54%
|
46%
| |
| B. New drugs/products to consider |
| 1. epoprostenol (FLOLAN) |
58% |
42%
|
40%
|
60%
| |
| 2. promethazine injection, IV |
60% |
40%
|
42%
|
58%
| |
| 3. oxytocin |
58% |
42%
|
42%
|
58%
| |